TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RCUS

Arcus Biosciences Inc

Healthcare · Biotechnology

25.50$ +3.6% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Arcus Biosciences Inc (RCUS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/27/2026.

Next report 10/27/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 14.6 % 23 Q4 23 · -8.0 % 23 Q1 24 · 118.5 % 24 Q2 24 · 26.6 % 24 Q3 24 · 6.5 % 24 Q4 24 · 14.4 % 24 Q1 25 · -12.9 % 25 Q2 25 · 100.0 % 25 Q3 25 · 1.6 % 25 Q4 25 · 19.1 % 25 Q1 26 · -22.9 % 26 Q2 26 · 26.5 % 26

EPS estimate beaten

Full history 22 of 36 quarters (61%)
Last 16 quarters 13 of 16 quarters (81%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/05/2026 Earnings Call Q1 2026 Open →
  • 02/25/2026 Earnings Call Q4 2025 Open →

News on This Stock

  • 08/05/2026 Arcus Biosciences, Inc. (RCUS): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?